Extracellular ATP Limits Homeostatic T Cell Migration Within Lymph Nodes




Kobayashi Daichi, Sugiura Yuki, Umemoto Eiji, Takeda Akira, Ueta Hisashi, Hayasaka Haruko, Matsuzaki Shinsuke, Katakai Tomoya, Suematsu Makoto, Hamachi Itaru, Yegutkin Gennady G, Salmi Marko, Jalkanen Sirpa, Miyasaka Masayuki

PublisherFrontiers Media SA

2021

Frontiers in Immunology

Frontiers in immunology

Front Immunol

12

1664-3224

1664-3224

DOIhttps://doi.org/10.3389/fimmu.2021.786595

https://research.utu.fi/converis/portal/detail/Publication/68761676



Whereas adenosine 5'-triphosphate (ATP) is the major energy source in cells, extracellular ATP (eATP) released from activated/damaged cells is widely thought to represent a potent damage-associated molecular pattern that promotes inflammatory responses. Here, we provide suggestive evidence that eATP is constitutively produced in the uninflamed lymph node (LN) paracortex by naïve T cells responding to C-C chemokine receptor type 7 (CCR7) ligand chemokines. Consistently, eATP was markedly reduced in naïve T cell-depleted LNs, including those of nude mice, CCR7-deficient mice, and mice subjected to the interruption of the afferent lymphatics in local LNs. Stimulation with a CCR7 ligand chemokine, CCL19, induced ATP release from LN cells, which inhibited CCR7-dependent lymphocyte migration in vitro by a mechanism dependent on the purinoreceptor P2X7 (P2X7R), and P2X7R inhibition enhanced T cell retention in LNs in vivo. These results collectively indicate that paracortical eATP is produced by naïve T cells in response to constitutively expressed chemokines, and that eATP negatively regulates CCR7-mediated lymphocyte migration within LNs via a specific subtype of ATP receptor, demonstrating its fine-tuning role in homeostatic cell migration within LNs.

Last updated on 2024-26-11 at 19:41